Yokosuka Akihito, Haraguchi Mitsue, Usui Takeo, Kazami Sayaka, Osada Hiroyuki, Yamori Takao, Mimaki Yoshihiro
Laboratory of Medicinal Pharmacognosy, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, 1432-1, Horinouchi, Hachioji, Tokyo 192-0392, Japan.
Bioorg Med Chem Lett. 2007 Jun 1;17(11):3091-4. doi: 10.1016/j.bmcl.2007.03.044. Epub 2007 Mar 19.
A new isoflavone, named glaziovianin A (1), was isolated from the leaves of Ateleia glazioviana (Legminosae) by means of a cytotoxicity-guided fractionation procedure against HL-60 leukemia cells. The chemical structure of 1 was determined by analysis of its extensive spectroscopic data. Glaziovianin A (1) displayed differential cytotoxicities in the Japanese Foundation for Cancer Research 39 cell line panel assay. The pattern of the differential cytotoxicities of 1 was found to correlate to that shown by TZT-1027, suggesting that 1 inhibited tubulin polymerization as an action mechanism. Although 1 had little influence on microtubule networks in interphase cells, 1-treated cells showed abnormal structures with unaligned chromosomes.
通过针对HL-60白血病细胞的细胞毒性导向分级分离程序,从豆科植物阿氏相思树(Ateleia glazioviana)的叶子中分离出一种新的异黄酮,命名为格拉齐奥宁A(1)。通过对其大量光谱数据的分析确定了1的化学结构。在日本癌症研究基金会39细胞系平板试验中,格拉齐奥宁A(1)表现出不同的细胞毒性。发现1的差异细胞毒性模式与TZT-1027所示的模式相关,这表明1作为一种作用机制抑制微管蛋白聚合。尽管1对间期细胞中的微管网络影响很小,但经1处理的细胞显示出染色体排列不齐的异常结构。